The Claim

Forced Canada and Mexico to take meaningful steps to address fentanyl trafficked into the U.S.

The Claim, Unpacked

What is literally being asserted?

Three factual components: (1) Canada and Mexico took “meaningful steps” to address fentanyl trafficking into the U.S., (2) these steps were the result of being “forced” by the Trump administration, and (3) these steps address fentanyl “trafficked into the U.S.” — implying Canada and Mexico are significant sources of fentanyl entering America.

What is being implied but not asserted?

That without the Trump administration’s pressure, Canada and Mexico would not have acted. That the mechanism of “force” — tariff threats under IEEPA — was both legal and effective. That fentanyl trafficking from both Canada and Mexico constitutes a comparable threat. That these “meaningful steps” actually reduced fentanyl reaching American communities. That coercive economic threats are the correct frame for describing what actually happened.

What is conspicuously absent?

Any acknowledgment that Mexico’s enforcement escalation under President Sheinbaum began in October 2024, months before Trump’s tariff threats. Any mention that Canada’s own Fentanyl Czar’s June 2025 interim report described fentanyl volumes crossing the northern border as “negligible” — approximately one-tenth of one percent of total U.S. border fentanyl seizures. Any acknowledgment that the IEEPA tariffs used as the “forcing” mechanism were struck down 6-3 by the Supreme Court in February 2026 as exceeding presidential authority. Any disclosure that the fentanyl decline was already well underway before any of these “forced” steps occurred, driven by China’s precursor chemical regulations, the Sinaloa cartel civil war, and expanded naloxone availability. Any mention of the massive economic damage the tariffs caused to American consumers and businesses — damage that the Supreme Court subsequently ruled was unauthorized.

Evidence Assessment

Established Facts

Canada and Mexico did take substantial enforcement actions in 2025, but the timeline undermines the “forced” narrative. Mexico deployed 10,000 National Guard troops to its northern border in February 2025, transferred 29 cartel leaders to U.S. custody in February 2025 and 26 more in August 2025 (over 50 total), seized 1.8 tons of fentanyl, destroyed nearly 1,900 clandestine laboratories, and arrested approximately 41,000 people linked to organized crime since President Sheinbaum took office in October 2024. However, Sheinbaum’s enforcement escalation began immediately upon taking office — more than three months before Trump’s February 2025 tariff threats. During her first six months (October 2024 - April 2025), Mexico dismantled over 750 drug labs and seized over 140 tons of narcotics. This timeline contradicts the claim that Trump “forced” these actions. [^046-a1]

Canada invested $1.3 billion in border security, appointed a Fentanyl Czar, and expanded surveillance — but its own government’s data shows the northern border fentanyl problem is vanishingly small. Canada announced its $1.3 billion Border Plan in December 2024 — before Trump’s tariff threats. Kevin Brosseau was appointed Fentanyl Czar in February 2025. Canada deployed Black Hawk helicopters (2,680 flight hours), 40 drones, and hired 2,000 new RCMP and CBSA personnel. It listed seven transnational criminal organizations as terrorist entities and launched a Joint Operational Intelligence Cell. However, Canada’s own Fentanyl Czar’s June 2025 interim report stated that fentanyl volumes crossing from Canada to the U.S. are “negligible” — approximately “one tenth of one percent” of U.S. border fentanyl seizures. In FY2024, just 43 pounds of fentanyl were seized at the northern border (0.2% of total), and only 0.74 pounds were determined to have actually originated in Canada. CNN’s fact-check found Canada makes up just 0.2% of U.S. border fentanyl seizures. [^046-a2]

The “forcing” mechanism — IEEPA tariffs — was ruled unconstitutional by the Supreme Court. On February 20, 2026, the Supreme Court ruled 6-3 in Learning Resources, Inc. v. Trump that IEEPA does not authorize the President to impose tariffs. Chief Justice Roberts wrote that “regulate” and “importation” in IEEPA “cannot bear such weight” and that the statute “contains no reference to tariffs or duties.” Both the “trafficking tariffs” on Canada, Mexico, and China (justified by fentanyl) and the broader “reciprocal tariffs” were struck down. The court applied the “major questions doctrine,” requiring clear congressional intent before delegating economically significant powers. Justice Kavanaugh noted the government “may be required to refund billions of dollars” to importers. The very mechanism the administration used to “force” these steps was found to exceed presidential authority. [^046-a3]

The tariff timeline involved repeated threats, pauses, reimpositions, and escalations — not a coherent enforcement strategy. On February 1, 2025, Trump announced 25% tariffs on Canada and Mexico and 10% on China under IEEPA, citing fentanyl. On February 3, tariffs on Mexico and Canada were paused for one month after both agreed to border enforcement measures. On March 4, 25% tariffs were imposed on both countries. In July 2025, tariffs on Canada were increased from 25% to 35%, with the White House framing this as punishment for “continued inaction and retaliation” despite Canada’s extensive enforcement measures. The tariff rates fluctuated repeatedly. In February 2026, the Supreme Court invalidated the entire IEEPA tariff framework. [^046-a4]

Strong Inferences

Mexico’s enforcement escalation was primarily driven by Sheinbaum’s policy reorientation, not Trump’s tariffs. Sheinbaum’s predecessor, President AMLO, had adopted a “hugs, not bullets” approach, shut down intelligence cooperation with the U.S., and disbanded an elite DEA-trained antinarcotics unit. Sheinbaum reversed this orientation upon taking office in October 2024 — months before Trump’s inauguration. Her security chief Omar Garcia Harfuch pursued aggressive cartel enforcement from day one. The Brookings Institution’s Vanda Felbab-Brown characterized Mexico’s response to tariff threats as “performative cooperation” — appearing to comply while negotiating on its own terms. The extradition of 29 cartel leaders in February 2025 coincided with tariff negotiations, but the infrastructure for this enforcement had been built over the preceding months. The 10,000 National Guard deployment was explicitly framed as a quid pro quo for a tariff pause, but Mexico had already been surging forces independently. [^046-a5]

Canada’s border security investments were disproportionate to the actual threat, suggesting political motivation rather than security necessity. Canada spent $1.3 billion, hired 2,000 personnel, deployed helicopters and drones, and appointed a Fentanyl Czar — all to address a problem its own government acknowledges is “negligible” (0.1% of U.S. fentanyl seizures). This disproportion suggests the measures were designed to provide political cover against tariff threats rather than to address a genuine security gap. Canada’s Fentanyl Czar explicitly acknowledged the context: “In February 2025, the U.S. issued tariffs against Canada, under the stated rationale that the flow of fentanyl and other illicit drugs across its Northern Border was a factor in the public health crisis.” The Globe and Mail found that nearly one-third of fentanyl seized and attributed to the U.S.-Canada border had no connection with Canada at all. [^046-a6]

Experts broadly agree that tariffs are ineffective as anti-fentanyl tools. STAT News called tariffs “manifestly ineffective” against fentanyl. The Brookings Institution argued they were “likely counterproductive” and would “eviscerate Beijing’s cooperation” on precursor chemicals. The American Enterprise Institute — a conservative think tank — published analysis titled “Two Charts Show Why a Trade War Over Fentanyl Doesn’t Make Sense.” A former member of the federal Commission to End the Fentanyl Crisis wrote in CNBC that “tariffs aren’t the way to do it.” WOLA published analysis titled “Tariffs Won’t Stop Fentanyl.” The expert consensus spans the political spectrum: tariffs are the wrong tool for this problem. [^046-a7]

The word “forced” obscures the diplomatic reality. Mexico’s 10,000-troop deployment was explicitly negotiated as a tariff-pause exchange. Canada’s $1.3 billion border plan was announced before Trump’s tariffs. Both countries’ enforcement actions continued independent of tariff fluctuations. Sheinbaum maintained cooperative diplomacy while simultaneously objecting to the tariff framework. Al Jazeera described her approach as maintaining a “cool head” to handle Trump. The relationship is better described as coercive diplomacy with preexisting enforcement trends, not “forcing” recalcitrant nations to act. [^046-a8]

Informed Speculation

The claim’s placement alongside Item #47 (“Implemented an additional 10% tariff on imports from China in order to stem the flow of illegal aliens and fentanyl”) reveals the administration’s preferred narrative: tariff threats forced reluctant foreign governments to address fentanyl. This narrative serves multiple functions. It justifies the tariffs themselves (which were primarily trade instruments, not anti-fentanyl measures). It positions the administration as the sole cause of enforcement improvements that were already underway. And it frames fentanyl as a foreign policy problem solvable through economic coercion, rather than a complex public health crisis requiring domestic demand reduction, treatment expansion, and multilateral cooperation.

The Supreme Court’s February 2026 ruling that IEEPA tariffs were unauthorized is particularly devastating for this claim. The administration “forced” Canada and Mexico to act using a mechanism that six Supreme Court justices — including three Trump appointees — found exceeded presidential authority. The “steps” that resulted from this coercion were either already in progress (Mexico’s enforcement under Sheinbaum), disproportionate to the actual problem (Canada’s $1.3 billion response to a 0.1% threat), or potentially counterproductive (Brookings warned tariffs would undermine China’s precursor chemical cooperation, which experts cite as a primary driver of declining fentanyl supply).

The economic damage from the tariffs dwarfs any fentanyl enforcement benefit. The Tax Foundation calculated the tariffs amounted to an average tax increase of $1,500 per U.S. household in 2026. Canada retaliated with tariffs on $155 billion of U.S. goods. China imposed 10-15% tariffs on U.S. agricultural imports. Mexico threatened 25% retaliatory tariffs. These trade disruptions are costs the “win” framing omits entirely.

Structural Analysis

Stated vs. revealed preferences. The stated preference is reducing fentanyl trafficking. The revealed preference is using fentanyl as justification for trade tariffs that serve broader economic objectives. The White House’s own fact sheets on tariff reimposition (March 2025) cited Mexico’s failure to address cartels — but the same administration praised Mexico’s cooperation weeks earlier when negotiating a tariff pause. The assessment shifted not based on Mexico’s enforcement record, which was consistently improving, but based on the administration’s tariff strategy.

The attribution problem. The fentanyl decline was driven by factors largely external to tariff coercion: China’s precursor chemical regulations (initiated under Biden), the Sinaloa cartel civil war, declining fentanyl purity, expanded naloxone availability, and Sheinbaum’s independent enforcement reorientation. Even if we credit the tariff threats with accelerating some enforcement actions (particularly Mexico’s 10,000-troop deployment and cartel extraditions), these were layered on top of preexisting trends that better explain the overall fentanyl decline. See Item #7 for the detailed causal analysis.

Cui bono. Framing tariffs as anti-fentanyl tools serves the administration’s trade agenda by wrapping economic protectionism in the politically untouchable cause of fighting drug deaths. It is far harder to criticize tariffs “to stop fentanyl” than tariffs to protect domestic industry, even though experts across the political spectrum say tariffs don’t work for this purpose.

The Canada problem. Including Canada alongside Mexico in this claim exposes the fentanyl framing as pretextual. Canada accounts for 0.2% of U.S. fentanyl seizures. Its own Fentanyl Czar calls the cross-border flow “negligible.” Yet it faced 25% tariffs (later raised to 35%) under the same fentanyl justification as Mexico, which is the origin point for approximately 97% of fentanyl seized at U.S. borders. If fentanyl were the genuine concern, the tariff rates would reflect the vastly different threat levels from each country. They did not, because fentanyl was the stated rationale, not the actual one.

Context the Framing Omits

Mexico’s enforcement escalation began under Sheinbaum in October 2024, not under Trump’s pressure. President Sheinbaum reversed her predecessor’s “hugs, not bullets” approach immediately upon taking office, months before Trump’s inauguration. Over 750 drug labs were dismantled and 140 tons of narcotics seized in her first six months. The enforcement infrastructure predated the tariff threats.

Canada’s $1.3 billion border plan was announced in December 2024 — before Trump’s tariffs. Prime Minister Trudeau announced the border security investment before the tariff threats materialized. The measures addressed a genuine domestic fentanyl crisis (7,146 Canadian overdose deaths in 2024) more than a cross-border trafficking issue.

The IEEPA tariffs were ruled unconstitutional. The Supreme Court’s 6-3 decision in Learning Resources, Inc. v. Trump (February 20, 2026) found that IEEPA does not authorize tariffs, invalidating the “forcing” mechanism entirely. The government may be required to refund billions.

Canada is not a significant source of U.S. fentanyl. Only 0.2% of U.S. fentanyl seizures occur at the northern border. Of those, only 0.74 pounds in FY2024 were determined to have originated in Canada. The southern border accounts for 97%+ of fentanyl seizures.

Tariffs caused massive economic damage to Americans. The Tax Foundation estimated the tariffs amounted to a $1,500 average tax increase per U.S. household. Canada, Mexico, and China imposed retaliatory tariffs, disrupting supply chains and increasing consumer prices. This cost is absent from the “win” calculation.

Expert consensus: tariffs don’t work for fentanyl. Analysts from Brookings, AEI, STAT News, WOLA, CNBC, and academic drug policy experts all agree tariffs are ineffective against drug trafficking and may be counterproductive by undermining cooperation.

The fentanyl decline has multiple causes unrelated to tariff coercion. As documented in Item #7, declining seizures and overdose deaths are driven by China’s precursor regulations (Biden-era), the Sinaloa cartel civil war, declining purity, and expanded naloxone availability. See Item #7 for full analysis.

Verdict

Factual core: Both Canada and Mexico did take enforcement actions in 2025 that can reasonably be described as “meaningful steps.” Mexico deployed 10,000 National Guard troops, transferred over 50 cartel figures to U.S. custody, seized 1.8 tons of fentanyl, and destroyed nearly 1,900 clandestine labs. Canada invested $1.3 billion in border security, appointed a Fentanyl Czar, deployed surveillance technology, and designated cartel organizations as terrorist entities.

The claim is misleading on three levels:

1. “Forced” mischaracterizes the causal relationship. Mexico’s enforcement escalation began under Sheinbaum in October 2024, months before Trump’s tariff threats. Canada’s $1.3 billion border plan was announced in December 2024, before tariffs. While the tariff threats likely accelerated some specific actions (particularly Mexico’s 10,000-troop deployment and extraditions), characterizing the entire enforcement shift as “forced” by Trump erases months of independent policy decisions by both countries.

2. The “forcing” mechanism was unconstitutional. The IEEPA tariffs used to coerce these steps were struck down 6-3 by the Supreme Court in February 2026. The administration “forced” allies to act using authority it did not legally possess, causing billions in economic damage to American consumers in the process.

3. The claim falsely equates Canada and Mexico as fentanyl threats. Canada accounts for 0.2% of U.S. fentanyl seizures. Its own Fentanyl Czar describes cross-border fentanyl as “negligible.” Grouping Canada with Mexico under the same fentanyl justification exposes the tariffs as primarily trade instruments using fentanyl as a politically useful pretext.

Framing as “win”: Misleading. Enforcement actions occurred, but “forced” overstates the administration’s causal role, understates preexisting trends, elides the unconstitutionality of the coercion mechanism, and omits the enormous economic costs to Americans. The claim takes credit for enforcement changes that were primarily driven by Sheinbaum’s policy reorientation in Mexico and Canada’s response to its own domestic fentanyl crisis, then attributes both to tariff threats that the Supreme Court found exceeded presidential authority.

What a reader should understand: Both Canada and Mexico expanded fentanyl enforcement in 2025 — that is real. Mexico’s actions were substantial: troop deployments, lab raids, and unprecedented extraditions. But Mexico’s enforcement escalation began in October 2024 under President Sheinbaum, months before Trump’s tariff threats. Canada invested heavily in border security, but its own government data shows cross-border fentanyl is negligible (0.2% of seizures), making the $1.3 billion investment and 25-35% tariffs wildly disproportionate to the actual threat. The tariffs used to “force” these steps were struck down by the Supreme Court in February 2026 as exceeding presidential authority under IEEPA. Experts across the political spectrum — from Brookings to AEI — agree tariffs are ineffective against fentanyl. The fentanyl decline itself is driven by factors documented in Item #7 (China’s precursor regulations, cartel civil war, declining purity, naloxone expansion) that predate and are largely independent of tariff coercion. The claim takes credit for enforcement trends it did not initiate, using a mechanism ruled unconstitutional, to address a problem (in Canada’s case) that barely exists.

Cross-References

• Item #7: “Cut fentanyl trafficking at the southern border by 56%” — the companion fentanyl claim. Item #7 establishes the multi-causal drivers of fentanyl decline (China’s precursor regulations, Sinaloa cartel civil war, declining purity, naloxone) that predate this administration’s actions. Item #46’s “forced” narrative conflicts with Item #7’s evidence that the decline was already well underway.
• Item #47: “Implemented an additional 10% tariff on imports from China in order to stem the flow of illegal aliens and fentanyl” — the tariff action that provides the “forcing” mechanism for this claim. Both claims use fentanyl to justify trade tariffs that experts say are ineffective against drug trafficking.

Sources

White House. “Fact Sheet: President Donald J. Trump Imposes Tariffs on Imports from Canada, Mexico and China.” February 1, 2025. https://www.whitehouse.gov/fact-sheets/2025/02/fact-sheet-president-donald-j-trump-imposes-tariffs-on-imports-from-canada-mexico-and-china/

White House. “Fact Sheet: President Donald J. Trump Proceeds with Tariffs on Imports from Canada and Mexico.” March 2025. https://www.whitehouse.gov/fact-sheets/2025/03/fact-sheet-president-donald-j-trump-proceeds-with-tariffs-on-imports-from-canada-and-mexico/

White House. “Fact Sheet: President Donald J. Trump Amends Duties to Address the Flow of Illicit Drugs Across Our Northern Border.” July 2025. https://www.whitehouse.gov/fact-sheets/2025/07/fact-sheet-president-donald-j-trump-amends-duties-to-address-the-flow-of-illicit-drugs-across-our-northern-border/

NPR. “America’s fentanyl crisis is improving but President Trump used the drug to justify tariffs.” February 2, 2025. https://www.npr.org/2025/02/02/nx-s1-5283957/fentanyl-trump-tariffs-china-canada-mexico

NPR. “Canada and China say the fentanyl crisis is only a ‘pretext’ for Trump’s new tariffs.” March 4, 2025. https://www.npr.org/2025/03/04/nx-s1-5317494/tariffs-fentanyl-canada-mexico-trump

Government of Canada. “Strengthening Canada’s Borders: 2025 in Review.” 2025. https://www.canada.ca/en/services/defence/securingborder/strengthen-border-security/2025-review.html

Government of Canada. “Canada’s Fentanyl Czar — Interim Report (June 2025).” June 2025. https://www.canada.ca/en/privy-council/services/publications/canada-fentanyl-czar-interim-report-june-2025.html

CNN. “Fact check: Canada makes up just 0.2% of US border fentanyl seizures.” February 3, 2025. https://www.cnn.com/2025/02/03/politics/us-canada-trade-fentanyl-fact-check

SCOTUSblog. “Supreme Court strikes down tariffs.” February 20, 2026. https://www.scotusblog.com/2026/02/supreme-court-strikes-down-tariffs/

Brookings Institution. “The Fentanyl Crisis: From Naloxone to Tariffs.” Vanda Felbab-Brown. March 2025. https://www.brookings.edu/articles/the-fentanyl-crisis-from-naloxone-to-tariffs/

STAT News. “Tariffs can’t defeat the fentanyl problem in the US.” Kathleen J. Frydl. July 3, 2025. https://www.statnews.com/2025/07/03/fentanyl-border-adjustments-tariffs-mexico-china-policy/

Anadolu Agency. “Mexico dismantles over 750 drug labs under Sheinbaum, causing ‘multi-million’ cartel losses, says security chief.” 2025. https://www.aa.com.tr/en/americas/mexico-dismantles-over-750-drug-labs-under-sheinbaum-causing-multi-million-cartel-losses-says-security-chief/3532259

U.S. Department of Justice. “37 Mexican Nationals Wanted for Serious Crimes Transferred to the United States from Mexico.” February 2025. https://www.justice.gov/opa/pr/37-mexican-nationals-wanted-serious-crimes-transferred-united-states-mexico-including

Congressional Research Service. “Presidential 2025 Tariff Actions: Timeline and Status.” https://www.congress.gov/crs-product/R48549

Tax Foundation. “Tariff Tracker: 2026 Trump Tariffs & Trade War by the Numbers.” https://taxfoundation.org/research/all/federal/trump-tariffs-trade-war/